<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Blumenthaler AN</submitter><funding>Holly Clegg Gastric Cancer Research Fund</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>911-922</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7906958</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>123(4)</volume><pubmed_abstract>&lt;h4>Background and objectives&lt;/h4>We sought to evaluate the impact of lymphovascular invasion (LVI) and perineural invasion (PNI) on survival outcomes in gastric cancer patients treated with preoperative therapy.&lt;h4>Methods&lt;/h4>Patients with gastric cancer treated with preoperative therapy and potentially curative resection were stratified according to the presence of LVI, PNI, or both. Kaplan-Meier and Cox regression analyses were used to evaluate the impact on overall survival (OS) and disease-free survival (DFS).&lt;h4>Results&lt;/h4>The study included 281 patients, of whom 93 (33%) had LVI, 69 (25%) had PNI, 51 (18%) had both LVI and PNI, and 170 (61%) had neither. LVI and PNI were each associated with higher ypT and ypN categories and more positive lymph nodes (all p &lt; .001), associations t</pubmed_abstract><journal>Journal of surgical oncology</journal><pubmed_title>Concurrent lymphovascular and perineural invasion after preoperative therapy for gastric adenocarcinoma is associated with decreased survival.</pubmed_title><pmcid>PMC7906958</pmcid><funding_grant_id>P30 CA016672</funding_grant_id><funding_grant_id>T32 CA009599</funding_grant_id><funding_grant_id>No Stomach For Cancer Award for Gastric Cancer Res</funding_grant_id><pubmed_authors>Ajani JA</pubmed_authors><pubmed_authors>Badgwell BD</pubmed_authors><pubmed_authors>Ikoma N</pubmed_authors><pubmed_authors>Newhook TE</pubmed_authors><pubmed_authors>Minsky BD</pubmed_authors><pubmed_authors>Mansfield PF</pubmed_authors><pubmed_authors>Estrella JS</pubmed_authors><pubmed_authors>Das P</pubmed_authors><pubmed_authors>Blum Murphy M</pubmed_authors><pubmed_authors>Blumenthaler AN</pubmed_authors></additional><is_claimable>false</is_claimable><name>Concurrent lymphovascular and perineural invasion after preoperative therapy for gastric adenocarcinoma is associated with decreased survival.</name><description>&lt;h4>Background and objectives&lt;/h4>We sought to evaluate the impact of lymphovascular invasion (LVI) and perineural invasion (PNI) on survival outcomes in gastric cancer patients treated with preoperative therapy.&lt;h4>Methods&lt;/h4>Patients with gastric cancer treated with preoperative therapy and potentially curative resection were stratified according to the presence of LVI, PNI, or both. Kaplan-Meier and Cox regression analyses were used to evaluate the impact on overall survival (OS) and disease-free survival (DFS).&lt;h4>Results&lt;/h4>The study included 281 patients, of whom 93 (33%) had LVI, 69 (25%) had PNI, 51 (18%) had both LVI and PNI, and 170 (61%) had neither. LVI and PNI were each associated with higher ypT and ypN categories and more positive lymph nodes (all p &lt; .001), associations t</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-04T19:53:49.586Z</modification><creation>2025-04-04T19:53:49.586Z</creation></dates><accession>S-EPMC7906958</accession><cross_references><pubmed>33400838</pubmed><doi>10.1002/jso.26367</doi></cross_references></HashMap>